Literature for oprozomib (XT01.001 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2014
1. Dou,Q.P. and Zonder,J.A.
   Overview of proteasome inhibitor-based anti-cancer therapies: Perspective on Bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system
   Curr Cancer Drug Targets14, 517-536. PubMed  Europe PubMed DOI  I
2013
2. McBride,A. and Ryan,P.Y.
   Proteasome inhibitors in the treatment of multiple myeloma
   Expert Rev Anticancer Ther13, 339-358. PubMed  Europe PubMed DOI  I